Risk of inventory write-downs due to weaker future demand and deteriorating market conditions
First written in FY2017. 5 of 8 entries say "Worsened", first in FY2018. Latest entry: FY2026.
The whole theme swung hardest in 2018: 10 of 37 companies on the "Worse" side.
- FY2026WorsenedAnnual report
「Cost of sales ¥326 million ¥332 million」
The inventory valuation loss increased from ¥326 million in the previous fiscal year to ¥332 million, and the risk of impairment losses increased in numerical terms. - FY2025WorsenedAnnual report
「Cost of sales 301 326」
The inventory valuation loss increased from ¥301 million in the previous fiscal year to ¥326 million, and the risk of impairment losses due to deteriorating future demand and market conditions increased in numerical terms. - FY2024WorsenedAnnual report
「Cost of sales ¥234 million ¥301 million」
The inventory valuation loss increased from ¥234 million in the previous fiscal year to ¥301 million. The risk of additional impairment losses due to deteriorating future demand and market conditions has increased in numerical terms. - FY2023WorsenedAnnual report
「The closing inventory balance is stated after a write-down to reflect the decline in profitability, and the following inventory valuation losses are included in cost of sales.」
The inventory valuation loss was ¥234 million, up from ¥204 million in the previous consolidated fiscal year. - FY2021Lower inventory valuation lossesAnnual report
「The period-end inventory balance is stated after a write-down to reflect lower profitability, and an inventory valuation loss of ¥221 million was recognized in the fiscal year.」
The inventory valuation loss decreased from ¥325 million in the previous fiscal year to ¥221 million, but the risk of additional impairment losses due to deteriorating future demand and market conditions remains. - FY2019RestatedAnnual report
「The period-end inventory balance is stated after a write-down to reflect lower profitability, and an inventory valuation loss of ¥166 million was recognized in the fiscal year.」
The inventory valuation loss was ¥166 million, a slight decrease from ¥167 million in the previous fiscal year. The risk of additional impairment losses due to deteriorating future demand and market conditions remains. - FY2018WorsenedAnnual report
「The period-end inventory balance is stated after a write-down to reflect lower profitability, and an inventory valuation loss of ¥167 million was recognized in the fiscal year.」
An inventory valuation loss of ¥167 million was recognized, up from ¥125 million in the previous fiscal year. - FY2017First statedAnnual report
「Our group recognizes the necessary impairment losses on inventories, based on estimates representing the difference between cost and estimated fair value, which reflects expected future demand and market conditions. If actual future demand or market conditions deteriorate more than estimated by management, additional impairment losses may be required.」
The potential for additional inventory impairment losses due to deteriorating future demand and market conditions is disclosed as a key accounting estimate.